AITRICS VitalCare vs Bayesian Health (2026)
Both predict sepsis and deterioration in hospitalized adults from routine EHR data, and their clearances differ. AITRICS VitalCare, from Seoul, works on general wards from up to 19 routine inputs, and publishes sensitivity, alarms per 100 patient days and lead time across two company led studies. Its 510(k) clears a rules based early warning dashboard, while the company claims clearance for its AI. Bayesian Health, a Johns Hopkins spinout, reads the record continuously and flags inpatients at rising risk, with order sets and documentation prepared for clinicians. Its sepsis module is FDA cleared, and it markets within that clearance. Choose VitalCare for a ward model with its alert burden published; choose Bayesian for a cleared sepsis model with the workflow built in.
- Your wards measure patients intermittently rather than continuously.
- You want sensitivity, alert burden and lead time published.
- Deterioration and sepsis should come from one model.
- You want a sepsis model that is FDA cleared and marketed within its clearance.
- Alerts should come with order sets and documentation ready.
- You may add modules for deterioration or readmissions later.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AITRICS VitalCare and Bayesian Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AITRICS VitalCare | Bayesian Health |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Founded | Not recorded | 2018 |
| Headquarters | Seoul, Republic of Korea | New York, New York, United States |
| Website | aitrics.com | bayesianhealth.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Bayesian Health
-
Regulatory / FDA
CMS approved a New Technology Add-on Payment for Bayesian Health's FDA cleared continuous AI sepsis monitor, creating Medicare payment support for health systems running the platform.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AITRICS is a Seoul medical AI company whose AITRICS-VC (VitalCare) predicts deterioration in hospitalized adults from routine electronic medical record data. It focuses on the general ward, where patients are measured intermittently rather than monitored continuously, so the models must work from sparse, irregular measurements.
Source: AI Health Index, September 2026
Bayesian Health, a Johns Hopkins spinout founded by Suchi Saria, sells a platform of machine learning models that read the EHR continuously and flag inpatients at rising risk, with workflows that prepare order sets and documentation for clinicians to act on. Its lead module detects sepsis early.
Source: AI Health Index, September 2026
Questions buyers ask
How do AITRICS VitalCare and Bayesian Health work with the EHR?
For AITRICS VitalCare, the US 510(k) describes the software analyzing patient data sourced from the EHR, and the product page describes connecting to the hospital's internal network to collect EMR data.
With Bayesian Health, the 510(k) summary calls the device's web application EHR agnostic and integrated into the EHR so clinicians see flags in their existing workflow, and the platform page says flags trigger workflows inside the EHR that tee up order sets, pathway steps and documentation. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How are AITRICS VitalCare and Bayesian Health priced and sold?
In AITRICS VitalCare's case, the product is sold to hospitals through an inquiry form, and in Korea it has entered the conditional new health technology assessment program, which bears on how it may be reimbursed there.
For Bayesian Health, the product is sold to health systems as an enterprise platform, by module, with implementation that tunes models to each site. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do AITRICS VitalCare and Bayesian Health handle patient data?
With AITRICS VitalCare, the company holds ISO/IEC 27701 privacy management certification alongside ISO 27001 (LRQA, October 2025) and describes de-identification and encryption procedures across its data lifecycle. Its privacy policy, written under Korea's Personal Information Protection Act, covers product inquiries, customer support and recruitment, not the ward data AITRICS-VC processes in hospitals.
In Bayesian Health's case, the company's privacy policy covers its marketing website. Nothing published states what patient data is retained, for how long, whether one health system's data develops models used by others, or who inside the company can reach identified records. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do AITRICS VitalCare and Bayesian Health cover?
For AITRICS VitalCare, the product covers inpatients 19 and older: adverse event and sepsis scores in general wards and a mortality score in the ICU under the Korean approval, while the US clearance covers only a rules-based general ward dashboard. The ward focus matters because ward patients are measured intermittently rather than continuously.
With Bayesian Health, the cleared sepsis module covers adults 18 and over from emergency department presentation or admission through the stay in acute care, including observation units, general wards and intensive care, and its evidence spans five hospitals in the outcome study and four in the clearance study, academic, urban and suburban. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
Both records were reviewed on this site in September 2026. Neither publishes a price. AITRICS's studies are company led, and its 510(k) clears a rules based dashboard rather than its AI. Bayesian's clearance reports agreement and positive predictive value, but no lead time was found in what was read.
Ask both for sensitivity, lead time and alerts per patient day from the same study.